4 Hydrologiske modeller 2
4.2 Distribuert HBV-modell
Comparando-se duas alternativas para o tratamento de síncope vasovagal, ou seja, o uso de fluoxetina (inibidor da recaptação de serotonina), e o treinamento físico moderado, sugere-se, analisando a recorrência de sintomas por doze semanas, que o treinamento físico tem um maior índice na diminuição dos sintomas. A atividade física é considerada benéfica para a saúde e também pode ser indicada para pessoas com síncope vasovagal como forma de tratamento. O exercício moderado, junto com o aumento da ingestão de água e sal, pode ser considerado um importante tratamento para pacientes com síncope vasovagal que ainda não experimentaram tratamento.
8.1 Limitações do estudo
Foi um estudo não randomizado, os pacientes foram escolhidos por conveniência, e a amostra foi pequena. O ideal seria o uso de um grupo controle, sem tratamento. Porém foi considerado inoportuno pelo grupo de pesquisadores, não indicar tratamento para os pacientes. Não foi avaliado se houve melhora no condicionamento físico dos pacientes, apesar de todos terem realizados os exercícios conforme a metodologia registrada.
REFERÊNCIAS BIBLIOGRÁFICAS
ABBOUD, F. Neurocardiogenic Syncope. NEJM. 328(15), p. 1117-1120, 1993.
ABE H, KONDO S, KOHSHI K, et al. Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. PACE. 25, p. 1454-1458, 2002
ABE H, KOHSHI K, NAKASHIMA Y. Effects of orthostatic self-training on head-up tilt testing and autonomic balance in patients with neurocardiogenic syncope. Journal of Cardiovascular Pharmacology. 41(suppl 1), p. S73-S76, 2003.
ACSM - American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. 6. ed. Canada: Williams & Wilkins, 2000, cap. 7.
AERTS AJJ, DENDALE P. Nitrate stimulated tilt table testing: a review of the literature. PACE. 26(7), p. 1528-37, 2003.
AMMIRATI F, COLIVICCHI F, BIFFI A, MAGRIS B, PANDOZI C, SANTINI M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J. 135, p. 671-6, 1998.
ARAYA-GOMEZ, Vivien. Síncope neurocardiogénico. Acta Méd. Costarric. vol.43(1), p. 11-19, 2001.
ASLAN O, GUNERI S, BADAK O, KIRIMLI O, GOLDELI O, KESKIN V, AKDENIZ B, TEKIN U. Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion. Can J Cardiol. 18(8), p. 853-9, 2002.
BALADY GJ, FLETCHER BJ, FROELICHER EF, HARTLEY LH, KRAUSS RM, OBERMAN A, POLLOCK ML, TAYLOR CB. Statement on cardiac rehabilitation programs. Circulation. 90, p. 1602–1610, 1994.
BARÓN-ESQUIVIAS G, CAYUELA A, GÓMEZ S, et al. Calidade de vida en los pacientes com síncope vasovagal. Influencia de parámetros clínicos. Med Clin (Barc). 121(7), p. 245- 9, 2003.
BÉCHIR M, BINGGELI C, CORTI R, CHENEVARD R, SPIEKER L, RUSCHITZKA F, LÜSCHER TF, NOLL G. Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation. 107, p. 1620-1625, 2003.
BENDITT D.G., ASSO A., REMOLE S., LURIE K. Tilt-table testing syncope. Current Opinion in Cardiology. 7, p. 37-45, 1992.
BENDITT D, CHEN MY, HANSEN R, et al. Characterization of subcutaneous microvascular blood flow during tilt table induced neurally mediated syncope. J Am Coll Cardiol. 25, p. 70-5, 1995.
BENDITT D, FERGUSON D, GRUBB B, et al. ACC Expert Consensus Document: Tilt table testing for assessing syncope. J Am Coll Cardiol. 28, p. 263-75, 1996a.
BENDITT DG, LURIE K, ADLER WS, SAKAGUCHI S, SCHULTZ J. Pathophysiology of Vasovagal Syncope. In: Blanc, J J; Benditt, D; Sutton, R, Eds. Neurally mediated syncope: Pathophysiology, investigation and treatment. 1st ed. Armonk: Futura Publishing Co.,
1996b, p. 1-24.
BENDITT DG, FAHY GJ, LURIE KG, SAKAGUCHI S, FABIAN W, SAMNIAH N. Pharmacotherapy of neurally mediated syncope. Circulation. 100, p. 1242-1248, 1999.
BENDITT DG, SUTTON R. Tilt-table in the evaluation of syncope. J Cardiovasc Electropysiol. 16, p. 356-358, 2005.
BIFFI M, BORIANI G, BRONZETTI G, et al. Neurocardiogenic syncope in selected pediatric patients - natural history during long-term follow-up and effect of prophylactic pharmacological therapy. Cardiovasc Drugs Ther. 15(2), p. 161-7, 2001.
BORG, G. Escalas de Borg para dor e o esforço percebido. São Paulo: Manole, 2000, p.115.
BRIGNOLE M (Chairperson), ALBONI P, BENDITT D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 22 (15), p. 1256-306, 2001.
BRIGNOLE M, CROCI F, MENOZZI C, SOLANO A, DONATEO P, ODDONE D, PUGGIONI E, LOLLI G. Isometric arm counter-pressure maneuvers to abort impeding vasovagal syncope. J Am Coll Cardiol. 40, p. 2054-2060, 2002.
BRIGNOLE M. Randomized clinical trials of neurally mediated syncope. J Cardiovasc Eletrophysiol. vol. 14 (suppl), p. S64-S69, 2003.
BRIGNOLE M. Neurally-mediated syncope. Ital Heart J. 6(3), p. 249-255, 2005.
BRITO JR HL, LANNA RP, BARAKY S. Síncope vasovagal e teste de inclinação (‘tilt- test’): revisão para padronização. Reblampa. 10(2), p. 78-86, 1997.
BRITO JR HL, BIANCHI FN, TOLEDO RM, et al. Teste de inclinação abreviado potencializado com dinitrato de isossorbida sublingual (1,25mg) versus teste basal prolongado: especificidade preservada? Arq Bras Cardiol. 74(supl. I), p. 20, 2000.
BROOKS R, RUSKIN JN. Evaluation of the patient with unexplained syncope. In: ZIPES DP, JALIFE J, (eds). Cardiac Electrophysiology. From Cell to Bedside. Philadelphia: WB Saunders Co., 1995, p. 1247-65.
BURKLOW TM, MOAK JP, BAILEY JJ, MAKHLOUF FT. Neurally mediated cardiac syncope: autonomic modulation after normal saline infusion. J Am Coll Cardiol. 33(7), p. 2059-66, 1999.
CALKINS, H. Pharmacologic approaches to therapy for vasovagal syncope. Am J Cardiol. 84, p. 20-25, 1999.
CARVELATTI D, PIZZI C, VISANI G, et al. Educational training program as treatment of patients with vasovagal syncope. J Am Coll Cardiol. 37(suppl 2), p. 513A, 2001.
CONVERTINO VA, MONTGOMERY LD, GREENLEAF JE. Cardiovascular responses during orhostasis: effect of an increase in VO2máx. Aviat Space Environ Med. 55, p. 702-8,
1984.
CONVERTINO VA. Aerobic fitness, endurance training, and orthostatic intolerance. Exer Sport Sci Rev. 15, p. 223-259, 1987.
CONVERTINO VA, DOERR DF, FLORES JF, et al. Leg size and muscle functions associated with leg compliance. J Appl Physiol. 64(3), p. 1017-1021, 1988.
CONVERTINO VA, THOMPSON CA, EXKBERG DL, et al. Baroreflex responses and lower blood negative pressure tolerance following exercise training. Physiologist. 33, p. 540– 1, 1990.
DI GIROLAMO E, DI IORIO C, LEONZIO L, SABATINI P, BARSOTTI A. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study. Circulation. 100, p. 1798-801, 1999.
ECTOR H, REYBROCUCK T, HEIDBUCHEL H, GEWILLIG M, VAN DE WERF F. Tilt Training: A new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. PACE. 21(II), p. 193-6, 1998.
ELLENBOGEN KA, MORILLO C, WOOD M, et al. Neural monitoring of vasovagal syncope. PACE. 20, p. 788-94, 1997.
EL-SAYED H, HAINSWORTH R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart. 75, 134-140, 1996.
ERMIS C, SAMNIAH N, LURIE KG, SAKAGUCHI S, BENDITT DG. Adrenal/renal contribution to circulating norepinephrine in posturally induced neurally mediated reflex syncope. Am J Cardiol. 91, p. 746-750, 2003.
FENTON AM, HAMMILL SC, REA RF, LOW PA, SHEN WK. Review: Vasovagal syncope. Ann Intern Med. 133, p. 714-725, 2000.
FITCHET A, STIRLING M, BURNETT G, et al. Holter Monitoring vs Tilt Testing in the inverstigation of suspected vasovagal syncope. PACE. 26, 1523-1527, 2003.
FLETCHER GF, BALADY G, FROELICHER VF, et al. Exercise standards. A statement for healthcare professionals from the American Heart Association writing group. Circulation. 91, p. 580-615, 1995.
FLETCHER GF, BALADY GJ, AMSTERDAM EA, et al. Exercise standards for testing and training: A statement for healthcare. Circulation. 104, p. 1694-1740, 2001.
FOGLIA-MANZILLOA G, GIADAB F, GAGGIOLIC G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace. 6, p. 199-204, 2004.
FURLAN R, PIAZZA S, DELL’ORTOS, et al. Cardiac autonomic patterns preceding ocasional vasovagal reactions in healthy humans. Circulation. 98, p. 1756-1761, 1998.
GOLDSTEIN DS, ELDADAH B, HOLMES C, et al. Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation. 111, p. 839-45, 2005.
GONZALEZ-HEYDRICH J, PEROUTKA SJ. Serotonin receptor and reuptake sites: pharmacologic significance. J Clin Psychiatry.51(suppl 4), p. 5–12, 1990
GREENLEAF JE, SCIARAVA D, SCHVARTZ E, et al. Exercise training hypotension: implications for plasma volume, renin and vasopressin. J Appl Physiol. 51(2), p. 298–305, 1981.
GRUBB BP, GERARD G, ROUSH K, et al. Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. Circulation. 84, p. 1157-1164, 1991.
GRUBB BP, KOSINSKI D, SAMOIL D. Recurrent unexplained syncope: The hole of head- upright tilt table testing. Heart & Lung. 22, p. 502-8, 1993a.
GRUBB BP, WOLFE DA, SAMOIL D, et al. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. PACE. 16, p. 458-64, 1993b.
GRUBB BP, SAMOIL D, KOSINSKI D, et al. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol. 24, p. 490-4, 1994a.
GRUBB BP, WOLFE DA, SAMOIL D, et al. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med. 97(4), p. 366-8, 1994b.
GRUBB BP, KOSINSKI D. Serotonin and syncope: an emerging connection? Eu J Cardiac Pacing Eletrophysiol. 5, p. 306-14, 1996.
GRUBB BP. Neurocardiogenic Syncope. In: Blair Grubb and Brian Olshansky eds. Syncope: Mechanisms and Management. Armonk: Futura Publishing Co. Inc., 1998, p. 73-106.
GRUBB BP. Neurocardiogenic syncope. N Engl J Med. 352, p. 1004-10, 2005.
GUIMARÃES JI (editor). Normatização dos equipamentos e técnicas para realização de exames de teste de inclinação ortostática (tilt table test). Arq Bras Cardiol. 79, p. 442-3, 2002.
HACHUL D, SOSA EA, CANSOLIM F, et al. Valor diagnóstico do teste de inclinação na avaliação da síncope de origem indeterminada. Resultados preliminares. Arq Bras Cardiol. 62, p. 7-9, 1994a.
HACHUL D, SOSA EA, CONSOLIM, F, et al. Reprodutibilidade do teste de inclinação em pacientes com Síncope Neurocardiogênica. Arq Bras Cardiol. 62 (n.5), p. 297-9, 1994b.
HACHUL D. Testes de inclinação seriados para avaliação da eficácia terapêutica da síncope neurocardiogênica. Rev Soc Cardiol Estado de São Paulo. vol.9(2), p. 253-60, 1999.
HACHUL D, SCANAVACCA M, SOSA M. Does a role exist for tilting-guided therapy in the management of neurocardiogenic syncope? Arq Bras Cardiol. 78, p. 167-71, 2002.
HAIDER J, KALUS JS, WHITE CM, et al. The effect of head-upright tilt table testing for vasovagal syncope on P-wave duration. Journal of Electrocardiology. 35(4), p. 303-6, 2002.
HAINSWORTH R. Exercise training in orthostatic intolerance. Q J Med. 91, p. 715-717, 1998.
HAYOZ D, NOLL G, PASSINO C, et al. Progressive withdrawal of muscle nerve sympathetic activity preceeding vaso-vagal syncope during lower-body negative pressure. Clin Sci. 91, p. 50-51, 1996.
HELLBRANDT FA, FRANSEEN EB. Physiological study of the vertical stance in man. Physiol Rev. 23, p. 220-225, 1993.
HILZ M.J, MARTHOL H, NEUNDÖRFER B. Syncope - A systematic overview of classification, pathogenesis, diagnosis and management. Fortschr Neurol Psychiatr. 70, p. 95-107 (abstract), 2002.
JARDINE DL, MELTON IC, CROZIER IG, et al. Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope. Am J Physiol – Heart Circ Physiol. 282, p. H1804-H1809, 2002.
JORDAN J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep. 7(1), p. 17-20 (abstract), 2005.
JULU POO, COOPER VL, HANSEN S, HAINSWORTH R. Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans. J Physiol. 549.1, p. 299-311, 2003.
KAPOOR WN, KARPF M, WIEAND. A prospective evaluation and follow-up of patients with syncope. N Engl J Med. 309, p. 197-204, 1983.
KAPOOR WN. Evaluation and outcome of patients with syncope. Medicine. 69, p. 160-175, 1990.
KAPOOR WN. Diagnostic evaluation of syncope. Am J Med. 90, p. 91-106, 1991.
KAPOOR WN. Evaluation and Management of Syncope. JAMA. 268, p. 2553-60, 1992.
KAPOOR WN, SMITH MA, MILLER NL. Upright tilt testing in evaluation syncope: A comprehensive literature review. Am J Med. 97, p. 78-88, 1994.
KAPOOR WN. Syncope and Hypotension. In: BRAUNWALD E. (ed). Heart Disease: A textbook of Cardiovascular Medicine. 5ª ed. Philadelphia: WB Sauders Company, 1997. p.
863-76.
KAPOOR WN. An overview of the evaluations and management of syncope. In: GRUBB B, OLSHANSKY B, (eds). Syncope: Mechanisms and Management. Armonk: Futura Publishing Company, 1998. p. 1-13.
KAPOOR WN, Using a tilt table to evaluate syncope. Am J Med Sci. 317, p. 110-116, 1999.
KAPOOR WN. Primary Care Syncope. N Engl J Med. 343, p. 1856-62, 2000.
KAPOOR WN. Current evaluation and management of syncope. Circulation. 106, p. 1606- 1609, 2002.
KAUFMANN H, BHATTACHARYA K. Diagnosis and treatment of neurally mediated syncope. The Neurologist. 8, p. 175-85, 2002.
KENNY RA, INGRAM A, BAYLISS J, SUTTON R. Head-Up tilt: A useful tool for investigating unexplained syncope. Lancet. 2, p. 1352-1354, 1986.
KIKUSHIMA S, KOBAYASHI Y, NAKAGAWA H, KATAGIRI T. Triggering mechanism for neurally mediated syncope induced by head-up tilt test: Role of catecholamines and response to propranolol. J Am Coll Cardiol. 33(2), p. 350-7, 1999.
KIM KH, CHO JG, LEE KO, et al. Usefulness of physical maneuvers for prevention of vasovagal syncope. Circ J. 69, p. 1084–88, 2005.
KINAY O, YAZICI M, NAZLI C, et al. Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J. 45(5), p. 833-43, 2004.
KORMANN DS, GAUCH PRA, TAKEDA RT, et al. Consenso para o implante de marcapasso cardíaco permanentemente e desfibrilador-cardioversor implantável – 1995, Deca-SBCCV. Reblampa. 8(1), p.4-11, 1995.
KOSINSKI D, GRUBB B. Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapy. Current Opinion in Cardiology. 9, .p 53-64, 1994.
KOSINSKI DJ, GRUBB BP, TEMESY-ARMOS PN. The use of serotonin re-uptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res. 1, p. 85–90, 1994.
KOSINSKI D, GRUBB BP, TEMESY-ARMOS PN. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. PACE. 18, p. 716-24, 1995.
KREDIET P, Van DIJK N, LINZER M, Van LIESHOUT JJ, WIELING W. Management of vasovagal syncope: Controlling or aborting faints by leg crossing and muscle tensing. Circulation. 106, p. 1684–89, 2002.
LAFUENTE EA, MARTÍNEZ LC, MOGUEL JO, et al. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope. Archives of Medical Research. 35, p. 416-420, 2004.
LIGHTFOOT JT, TOTOK DJ, JOURNELL TW, et al. Resistance training increases lower body negative pressure tolerance. Med Sci Sports Exerc. 26, p. 1003-1011, 1994.
LINZER M, FELDER A, HACKEL A, et al. Psychiatric syncope: A new look at an old disease. Psychosomatics. 31, p. 181-8, 1990.
LINZER M. Syncope: 1991 (Editorial). Am J Med. 90, p. 1-5, 1991.
LINZER M, PONTINEN M, GOLD DT, et al. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 44, p. 1037-1043, 1991.
LINZER M, GOLD DT, PONTINEN M, et al. Recurrent syncope as a chronic disease. J Gen Intern Med. 9, p. 181-6, 1994.
LURIE K, BENDITT D. Syncope and the autonomic nervous system. J Cardiovasc Electrophysiol. 7, p. 760-76, 1996.
LU CC, DIEDRICH A, TUNG CS, et al. Water ingestion as prophylaxis against syncope. Circulation. 108, p. 2660-2665, 2003.
MAGERKURTH C, RIEDEL A, BRAUNE S. Permanent increase in endothelin serum levels in vasovagal syncope. Clin Auton Res. 15, p. 299-301, 2005.
MALONEY JD, JAEGER FJ, FOUAD-TARAZI FM, MORRIS HH. Malignant Vasovagal syncope: prolonged asystole provoked by head-up tilt. Cleve Clin J Med. 55, p. 542-8, 1988.
MANGRU NN, YOUNG ML, MAS MS, et al. Usefulness of tilt table test with normal saline infusion in management of neurocardiac syncope in children. Am Heart J. 131, p. 953-955, 1996.
McCARTHY JP, BAMMAN MM, YELLE JM, et al. Resistance exercise training and the orthostatic response. Eur J App Physiol Occup Physiol. 76 (1), p. 32-40, 1997.
MITTAL S, STEIN KM, MARKOWITZ SM, et al. Induction of neurally-mediated syncope with adenosine. Circulation. 99, p. 1318-1324, 1999.
MORGAN DA, THOREN P, WILCZYNSKI EA, ViCTOR RG, MARK AL. Serotoninergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats. Am J Physiol. 255, p. H496–H502, 1988.
MORILLO C, KLEIN G, SANDRI S, et al. Diagnostic accuracy of a low dose isoproterenol head up tilt protocol. Am Heart J. 129, p. 901-6, 1995.
MORILLO CA, ECKBERG DL, ELLENBOGEN KA, et al. Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation. 96, p. 2509-2513, 1997.
MOSQUEDA-GARCIA R, FURLAN R, TANK J, FERNANDEZ-VIOLANTE R. The elusive pathophysiology of neurally mediated syncope. Circulation. 102, p. 2898-2906, 2000.
MTINANGI BL, CROFT JS, BROWN CM, HAINSWORTH R. Effects of an exercise training programme on plasma volume and orthostatic tolerance in humans. J Physiol. 497, p. 68, 1996.
MTINANGI BL, HAINSWORTH R. Increased orthostatic tolerance following moderate exercise training in patients with unexplained syncope. Heart. 80, p. 596–600, 1998.
MTINANGI BL, HAINSWORTH R. Effects on moderate exercise training on plasma volume, baroreceptor sensivity and orthostatic tolerance in healthy subjects. Exp Physiol. 84 (1), p. 121-130, 1999.
MURATORE C, RABINOVICH R, VALENTINO M, BARANCHUK A, LIPRANDI AS. Tilt test para la evaluacion del sincope de origen desconocido. Medicina. 57(2), p. 139-142, 1997.
NAIR N, PADDER FA, KANTHARIA BK. Pathophysiology and management of neurocardiogenic syncope. The Am J Managed Care. vol. 9(4), p. 327-334, 2003.
NELSON SD, STANLEY M, LOVE CJ, COYNE KS, SHAAL SF. Autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syndrome. Arch Intern Med. 151, p. 2425-2429, 1991.
NOBREGA ACL (editor). Diretriz da sociedade brasileira de medicina do esporte: morte súbita no exercício e no esporte. Rev Bras Med Esporte. vol. 1(supl. 1), p. S1-S8, 2005.
ONO T, SAITOH H, ATARASHI H, HAYAKAWA H. Abnormality of alpha-adrenergic vascular response in patients with neurally mediated syncope. Am J Cardiol. 82, p. 438-443, 1998.
PÊGO-FERNANDES P, COSTA R, AMATO M, et al. A erradicação da síncope vasovagal maligna pela estimulação cardíaca artificial. Reblampa. 7, p. 58-61, 1994.
PIETRUCHA AZ, FUDAL A, WEGRZYNOWSKA M, et al. Psychological evaluation of patients with vasovagal syncope. Europace supplements. 7, p. S4, 2005.
PITZALIS M, PARATI G, MASSARI F, et al. Enhanced reflex response to baroreceptor deactivation in subjects with tilt-induced syncope. J Am Coll Cardiol. 41(7), p. 1167-73, 2003.
PLOUTZ LL, TATRO DL, DUDLEY G, CONVERTINO VA. Changes in plasma volume and baroreflex function following resistance exercise. Clin Physiol. 13, p. 429-438, 1993.
POLLOCK ML, GAESSER GA, BUTCHER JD. et al. ACSM: The recommended quantity and quality of exercise for development and maintaining cardiorespiratory and muscular fitness and flexibility in healthy adults. Med Scie Sports Exerc. 30, p. 975–991, 1998.
QUAN KJ, CARLSON MD, THAMES MD. Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope. PACE. v. 20, p. 764-74, 1997.
RAVIELE A, GASPARINI G, Di PEDE F, DELISE P, BONSO A, PICOLO E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol. v. 65: p. 1322-7, 1990.
RAVIELE A, GASPARINI G, Di PEDE F, et al. Nitroglycerin infusion during upright tilt: A new test for the diagnosis of vasovagal syncope. Am Heart J. 127, p. 103-11, 1994.
REA R, THOMAS MD. Neural Control and vasovagal syncope mechanisms. J Cardiovasc Electrhphysiol. v. 4, p. 587-595, 1993
SAADJIAN AY, LÉVY S, FRANCESCHI F, et al. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation. 106, p. 569-574, 2002.
SAMOIL D, GRUBB BP. Neurally mediated syncope and serotonin reuptake inhibitors. Clinical Autonomic Research. 5, p. 251-255, 1995.
SCANAVACCA MI (Coordenador), et al. Diretrizes para avaliação e tratamento de pacientes com arritmias cardíacas. Arq Bras Cardiol. 79 (supl. V), p. 1-10, 2002.
SCHERRER U, VISSING S, MORGAN BJ, HANSON P, VICTOR RG. Vasovagal syncope after infusion of a vasodilatador in a heart-transplant patient. N Engl J Med. 322(9), p. 602- 604, 1990.
SCHNIPPER JL, KAPOOR WN. Cardiac Arrhythmias - Diagnostic evaluation and management of patients with syncope. In: Cardiac Arrhythmias. Medical Clinics of North America. Pittsburgh: W. B. Saunders Company, v. 85 (2), 2001. p. 1-27.
SHELDON R. Tilt testing for syncope: a reappraisal. Curr Opin Cardiol. 20, p. 38-41, 2004.
SHVARTZ E. Endurance fitness and orthostatic tolerance. Aviat Space Environ Med. 67(10), p. 935-9, 1996.
SMITH ML, RAVEN PB. Cardiovascular responses to lower body negative pressure in endurance and static exercise trained men. Med Sci Sports Exerc. 18(5), p. 545–50, 1986.
SMITH ML, CARLSON MD, THAMES MC. Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. J Auton Nerv System. 45, p. 1–9, 1993.
SOTERIADES ES, EVANS JC, LARSON MG, et al. Incidence and prognosis of syncope. NEJM. 247(12), p. 878-885, 2002.
SUTTON R, PETERSEN M, BRIGNOLE M, et al. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol. 2, p. 180-3, 1992.
SUTTON R, BLOOMFIELD D. Indications, methodology and classification of results of tilt table test. Am J Cardiol. 84, p. 10-9, 1999.
THOMSON HL, WRIGHT K, FRENNEAUX M. Baroreflex sensitivity in patients with vasovagal syncope. Circulation. 95, p. 395-400, 1997.
UDANI V, BAVDEKAR M, KARIA S. Head up tilt test in the diagnosis of neurocardiogenic syncope in childhood and adolescence. Neurol India. 52, p. 185-187, 2004.
VAN DIJK N, BRUIN IJGM, GISOLF J, et al. Hemodynamic effects of leg crossing and skeletal muscle tensing during free standing in patients with vasovagal syncope. J Appl Physiol. 98, p. 584-590, 2005.
VAN LIESHOUT JJ, WIELING W, KAREMAKER JM, ECKBERG DL. The vasovagal response. Clin Sci. 81, p. 575-586, 1991.
VAN LIESHOUT JJ, WIELING W, KAREMAKER JM. Neural circulatory control in vasovagal syncope. PACE. 20, p. 753-63, 1997.
VAN LIESHOUT JJ, WIELING W, KAREMAKER JM, SECHER NH. Syncope, cerebral perfusion, and oxygenation. J Appl Physiol. 94, p. 833-848, 2003.
WARLTIER DC, CAMPAGNA JA, CARTER C. Clinical relevance of the Bezold-Jarisch Reflex - Review article. Anesthesiology. 98(5), p. 1250-60, 2003.
WIELING W, VAN LIESHOUT JJ, HAINSWORTH R. Extracellular fluid volume expansion in patients with posturally related syncope. Clin Auton Res. 12, 242-249, 2002.
WINKER R. Orthostatische intoleranz – prävalenz, diagnostic und die bedeutung für die arbeitsmedizin. Wien Klin Wochenschr. 116(suppl 1), p. 40-46, 2004.
WINKER R, BARTH A, BIDMON D, et al. Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension. 45(3), p. 391-8, 2005.
WHITE CM, TSIKOURIS JP. A review of pathophysiology and therapy of patients with vasovagal syncope. Pharmacotherapy. 20(2), p. 158-165, 2000.